nVerses Capital »

Summit Therapeutics shares owned by nVerses Capital

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by nVerses Capital from 13F filings

Historical chart of nVerses Capital investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by nVerses Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $259k 18k 14.57

More positions owned by nVerses Capital

CenterPoint Energy (CNP)
Abbvie (ABBV)
Knight-swift Transn Hldgs In Cl A (KNX)
Wal-Mart Stores (WMT)
Target Corporation (TGT)
Peoples Ban (PEBO)
Delta Air Lines Com New (DAL)
Astrana Health Com New (ASTH)
SM Energy (SM)
American Superconductor Corp Shs New (AMSC)
Mirum Pharmaceuticals (MIRM)
Arthur J. Gallagher & Co. (AJG)
Wright Express (WEX)
Mosaic (MOS)
Marriott Vacations Wrldwde Cp (VAC)

View all positions for nVerses Capital

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
BlackRock
T. Rowe Price Associates
State Street Corporation
Vanguard Capital Management
UBS Group
Vanguard Portfolio Management
Goldman Sachs Group
Point72 Asset Management
Geode Capital Management
Citadel Advisors
Susquehanna International
Millennium Management
Adage Capital Partners GP

View all funds holding Summit Therapeutics